Tg Therapeutics, Inc. · NASDAQ:TGTX
State Street Corp's stake in Tg Therapeutics, Inc. fell to 4.70% (Schedule 13G)
Event Mar 31, 2025 · Filed May 13, 2025
State Street Corp's stake in Tg Therapeutics, Inc. fell to 4.70%, 7,433,899 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G).
- Stake
- 4.70%
- Shares
- 7,433,899
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.70% | 7,433,899 |
Source
Related
- Tg Therapeutics, Inc.
- State Street Corp
- Tg Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Nov 10, 2025
- Form 4 · Charney Laurence N · Sep 14, 2026
- Form 4 · Charney Laurence N · Aug 7, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 29, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 30, 2025